Identification of hypoxia-inducible factor HIF1A as a therapeutic target during SARS-CoV-2-associated lung injury.
Bobrow B, Luber SD, Potnuru P, Figarella K, Kim J, Wang Y, Bang IH, Robinson D, Sergot PB, Burke SK, Mills T, de Dios C, Suchting R, Williams GW, Ginde AA, Liang Y, Liu H, Green C, Doursout MF, Turan A, Sessler DI, Yuan X, Eltzschig HK.
Bobrow B, et al. Among authors: robinson d.
JCI Insight. 2025 Jun 17:e191463. doi: 10.1172/jci.insight.191463. Online ahead of print.
JCI Insight. 2025.
PMID: 40526427
Free article.